Alzheimer's disease is on the rise, but the University of Kentucky Sanders-Brown Center on Aging is a major player in the fight against this debilitating condition. Since the founding of the SBCoA in 1979, and the federal funding of the SBCoA Alzheimer's Disease Center (ADC) in 1985, the center has made many contributions to the body of knowledge about Alzheimer's and related brain aging conditions.
The facts about Alzheimer's disease are staggering. An estimated 5.2 million Americans and approximately 34 million people worldwide have Alzheimer’s and other dementias.
The National Institutes of Health (NIH) awarded $20 million to the University of Kentucky to move research discoveries to health care solutions more quickly. The five-year funding, awarded through the NIH's institutional Clinical and Translational Science Awards program, is the largest research funding award ever received by UK and will be used to support research at UK's Center for Clinical and Translational Science, making it part of a select national biomedical research consortium. The UK center is led by Dr.
The University of Kentucky has developed several research strengths, particularly in therapeutic areas that have high prevalence in Kentucky. These strengths include research into cancer, substance abuse, neurological diseases and cardiovascular sciences.
University of Kentucky is part of an elite group of medical centers across the country who have earned the "trifecta" of national federal funding.
Researchers at UK have discovered a new cellular mechanism that may better explain what causes amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. ALS is a neurodegenerative disease that involves the death of motor neurons, leading to the muscle weakness and atrophy.
